 |
arsenic trioxide capsule (oral) |
|---|---|
| Trade Name | |
| Orphan Indication | Acute promyelocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-02 00:00:00 |
| Sponsor | Orsenix Holdings BV;1105 North Market Street, Suite 1800;Wilmington, Delaware, 19801 |
Related Access Program